Scaffold Vascularization Method Using an Adipose-derived Stem Cell (ASC)-seeded Scaffold Prefabricated with a Flow-through Pedicle
Overview
Authors
Affiliations
Background: Vascularization is important for the clinical application of tissue engineered products. Both adipose-derived stem cells (ASCs) and surgical prefabrication can be used to induce angiogenesis in scaffolds. Our aim was to compare the angiogenic potential of ASC-seeded scaffolds combined with scaffold prefabrication with that of non-seeded, non-prefabricated scaffolds.
Methods: For prefabrication, functional blood vessels were introduced into the scaffold using a flow-through pedicle system. ASCs were isolated from rat fat deposits. Three-dimensional-printed cylindrical poly-ε-caprolactone scaffolds were fabricated by fused deposition modelling. Three groups, each containing six rats, were investigated by using non-seeded, ASC-seeded, and osteogenic induced ASC-seeded scaffolds. In each group, one rat was implanted with two scaffolds in the inguinal region. On the right side, a scaffold was implanted subcutaneously around the inferior epigastric vessels (classic prefabrication group). On the left side, the inferior epigastric vessels were placed inside the prefabricated scaffold in the flow-through pedicle system (flow-through prefabrication group). The vessel density and vascular architecture were examined histopathologically and by μCT imaging, respectively, at 2 months after implantation.
Results: The mean vessel densities were 10- and 5-fold higher in the ASC-seeded and osteogenic induced ASC-seeded scaffolds with flow-through prefabrication, respectively, than in the non-seeded classic prefabricated group (p < 0.001). μCT imaging revealed functional vessels within the scaffold.
Conclusion: ASC-seeded scaffolds with prefabrication showed significantly improved scaffold vasculogenesis and could be useful for application to tissue engineering products in the clinical settings.
Exosome-loading miR-205: a two-pronged approach to ocular neovascularization therapy.
Zhang H, Zhang Q, Liu Q, Feng S, Ma Y, Wang F J Nanobiotechnology. 2025; 23(1):36.
PMID: 39844301 PMC: 11756024. DOI: 10.1186/s12951-024-03079-y.
Iqbal M, Riaz M, Biedermann T, Klar A Angiogenesis. 2024; 27(4):587-621.
PMID: 38842751 PMC: 11564345. DOI: 10.1007/s10456-024-09928-6.
Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting.
Del Amo C, Andia I Int J Bioprint. 2023; 9(5):762.
PMID: 37457947 PMC: 10339460.
Tissue Engineering Strategies for Treating Avascular Necrosis of the Femoral Head.
Murab S, Hawk T, Snyder A, Herold S, Totapally M, Whitlock P Bioengineering (Basel). 2021; 8(12).
PMID: 34940353 PMC: 8699035. DOI: 10.3390/bioengineering8120200.
Bioactive Nanofiber-Based Conduits in a Peripheral Nerve Gap Management-An Animal Model Study.
Debski T, Kijenska-Gawronska E, Zolocinska A, Siennicka K, Slysz A, Paskal W Int J Mol Sci. 2021; 22(11).
PMID: 34070436 PMC: 8197537. DOI: 10.3390/ijms22115588.